France Animal Vaccines Market Size & Outlook, 2024-2030

The animal vaccines market in France is expected to reach a projected revenue of US$ 659.0 million by 2030. A compound annual growth rate of 9.8% is expected of France animal vaccines market from 2025 to 2030.
Revenue, 2024 (US$M)
$380.6
Forecast, 2030 (US$M)
$659.0
CAGR, 2025 - 2030
9.8%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France animal vaccines market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France animal vaccines market highlights

  • The France animal vaccines market generated a revenue of USD 380.6 million in 2024 and is expected to reach USD 659.0 million by 2030.
  • The France market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
  • In terms of segment, attenuated live vaccines was the largest revenue generating product in 2024.
  • Inactivated Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.

Animal vaccines market data book summary

Market revenue in 2024USD 380.6 million
Market revenue in 2030USD 659.0 million
Growth rate9.8% (CAGR from 2025 to 2030)
Largest segmentAttenuated live vaccines
Fastest growing segmentInactivated Vaccines
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAttenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines
Key market players worldwideZoetis, Ceva Santé Animale, Merck & Co Inc, Vetoquinol SA, Boehringer Ingelheim, Elanco Animal Health Inc, Virbac SA, Veterinary Pharmaceutical Solutions, Dechra Pharmaceuticals, IDEXX Laboratories Inc, Norbrook

Other key industry trends

  • In terms of revenue, France accounted for 2.8% of the global animal vaccines market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK animal vaccines market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 608.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Animal Vaccines Market Companies

Name Profile # Employees HQ Website
Ceva Santé Animale View profile 5001-10000 Libourne, Aquitaine, France, Europe https://www.ceva.us
Norbrook View profile 1001-5000 Newry, Newry and Mourne, United Kingdom, Europe http://www.norbrook.com
Dechra Pharmaceuticals View profile 501-1000 Northwich, Cheshire, United Kingdom, Europe http://www.dechra.com
Veterinary Pharmaceutical Solutions View profile 11-50 Saint Peter, Minnesota, United States, North America https://veterinarypharmaceuticalsolutions.com
Zoetis View profile 10001+ Parsippany, New Jersey, United States, North America https://www.zoetis.com
Vetoquinol SA View profile 2483 Magny-Vernois, BP 189, Lure cedex, France, 70204 http://www.vetoquinol.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
IDEXX Laboratories Inc View profile 11000 One IDEXX Drive, Westbrook, ME, United States, 04092 https://www.idexx.com
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com

France animal vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal vaccines market will help companies and investors design strategic landscapes.


Attenuated live vaccines was the largest segment with a revenue share of 40.65% in 2024. Horizon Databook has segmented the France animal vaccines market based on attenuated live vaccines, inactivated vaccines, subunit vaccines, dna vaccines, recombinant vaccines covering the revenue growth of each sub-segment from 2018 to 2030.


  • France Animal Vaccines Product Outlook (Revenue, USD Million, 2018-2030)
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Attenuated Live Vaccines
    • DNA Vaccines
  • France Animal Vaccines Animal Type Outlook (Revenue, USD Million, 2018-2030)
    • Companion
      • Canine
      • Feline
      • Others
    • Livestock
      • Poultry
      • Aqua
      • Ruminants
      • Swine
  • France Animal Vaccines Route of administration Outlook (Revenue, USD Million, 2018-2030)
    • Subcutaneous
    • Intramuscular
    • Intranasal
  • France Animal Vaccines Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Retail
    • E-Commerce
    • Hospital/ Clinic Pharmacy

Reasons to subscribe to France animal vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France animal vaccines market databook

  • Our clientele includes a mix of animal vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France animal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into France animal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France animal vaccines market size, by companion, 2018-2030 (US$M)

France Animal Vaccines Market Outlook Share, 2024 & 2030 (US$M)

France animal vaccines market size, by companion, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online